Research Article
Laboratory Investigation (2006) 86, 1285–1292. doi:10.1038/labinvest.3700486; published online 16 October 2006
Expression and localization of PDGF-B, PDGF-D, and PDGF receptor in the kidney of angiotensin II-infused rat
Nobukazu Ishizaka1, Gen Matsuzaki1, Kan Saito1, Eisei Noiri2, Ichiro Mori3 and Ryozo Nagai1
- 1Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
- 2Department of Nephrology, University of Tokyo Graduate School of Medicine, Tokyo, Japan
- 3Department of Pathology, Wakayama Medical College, Tokyo, Japan
Correspondence: Dr N Ishizaka, MD, PhD, Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail: nobuishizka-tky@umin.ac.jp
Received 2 May 2006; Revised 4 September 2006; Accepted 11 September 2006; Published online 16 October 2006.
Abstract
Lipid accumulation in the kidney is a marker of tissue damage and may play a role in the development of renal injury. We have previously shown that long-term administration of angiotensin II in rats causes increased expression of transforming growth factor-
1, coupled with an accumulation of lipids in the tubular and vascular wall cells in the kidney. In this study, we examine the regulation of expression of platelet-derived growth factor (PDGF) and its receptor system and their co-localization with lipid deposits in the kidneys of angiotensin II-infused rats. Real-time RT-PCR showed that expression of PDGF-B, PDGF-D, and PDGF receptor-
(PDGFR-
) mRNA was increased by angiotensin II infusion, and in situ hybridization showed the co-localization of these mRNAs. Tubular cells that had increased PDGF-B mRNA expression were positive for lipid deposition and also for cellular proliferation, which was indicated by the presence of proliferating cell nuclear antigen. By contrast, in the kidneys of angiotensin II-infused rats, apoptosis occurred in tubular cells that contained deposits of iron but not lipids. The deposition of lipids and upregulation of PDGF-B, PDGF-D, and PDGFR-
induced by administration of angiotensin II were all suppressed by the selective angiotensin II type 1 (AT1) receptor antagonist losartan, but not by the nonspecific vasodilator hydralazine. The findings that lipid accumulation, upregulation of PDGF-B, PDGF-D, and PDGFR-
, and cellular proliferation were topologically associated and regulated in an AT1 receptor-dependent manner in the kidney of angiotensin II-infused rats suggests that these phenomena are related.
Keywords:
angiotensin II, hypertension, platelet-derived growth factor, lipid accumulation, apoptosis
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Molecular basis for sunitinib efficacy and future clinical development
Nature Reviews Drug Discovery Review (01 Sep 2007)
RESEARCH
Kidney International Original Article
Laboratory Investigation Research Article
Abnormal Iron Deposition in Renal Cells in the Rat with Chronic Angiotensin II Administration
Laboratory Investigation Article Response
PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor
Nature Cell Biology Brief Communication (01 May 2001)

